RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Ypsomed Holding Stock

Ypsomed Holding Stocks 2024

Ypsomed Holding Stocks

13.65 M

Ticker

YPSN.SW

ISIN

CH0019396990

WKN

A0B8VP

In 2024, Ypsomed Holding had 13.65 M outstanding stocks, a 1.72% change from the 13.42 M stocks in the previous year.

The Ypsomed Holding Stocks history

YEARNUMBER OF STOCKS (undefined CHF)
2030e13.65
2029e13.65
2028e13.65
2027e13.65
2026e13.65
2025e13.65
202413.65
202313.42
202212.65
202112.61
202012.6
201912.6
201812.59
201712.61
201612.62
201512.62
201412.6
201312.6
201212.6
201112.6
201012
200911.2
200811.2
200711.2
200611.2
200511.2

Ypsomed Holding shares outstanding

The number of shares was Ypsomed Holding in 2023 — This indicates how many shares 13.419 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Ypsomed Holding earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Ypsomed Holding's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Ypsomed Holding’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Ypsomed Holding's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Ypsomed Holding Aktienanalyse

What does Ypsomed Holding do?

Ypsomed Holding AG is a Swiss company specialized in the development and production of medical products. It started in the 1980s when the founder, Willy Michel, established his own company focusing on the production of insulin pens. Today, it has become one of the largest providers of injector systems in Europe. Ypsomed's business model is based on focusing on niche products in medical technology and developing innovative solutions for specific medical problems. It also collaborates closely with leading clinics, research institutions, and other partners to develop new products and improve existing technologies. Ypsomed is divided into different business divisions. One of the largest divisions is Diabetes Care, specializing in the development and production of insulin pens and pumps. Ypsomed is a significant supplier of devices and accessories for some of the world's largest pharmaceutical companies. Another important division of Ypsomed is SelfCare, focused on the development and production of medication delivery systems for self-medication by patients. The offerings range from pen systems to auto-injectors, inhalers, and nasal spray systems. Ypsomed also offers a range of other products, including infection control systems, injection systems for veterinary medicine, and specialty products for wound care. In addition to its products, Ypsomed stands out for its focus on research and development. The company regularly invests in new technologies to find better solutions for medical problems and works closely with leading clinics and research institutions worldwide. Overall, Ypsomed is a leading provider of medical products and solutions for specific medical problems. The company operates in more than 80 countries and has gained a reputation as an innovative partner in the medical technology industry. Ypsomed Holding ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Ypsomed Holding's Shares Outstanding

Ypsomed Holding's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Ypsomed Holding’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Ypsomed Holding’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Ypsomed Holding’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Ypsomed Holding stock

How many stocks are there of Ypsomed Holding?

The current number of stocks of Ypsomed Holding is 13.65 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Ypsomed Holding are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Ypsomed Holding evolved in recent years?

The number of shares of Ypsomed Holding has increased by 1.72% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Ypsomed Holding as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Ypsomed Holding?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Ypsomed Holding pay?

Over the past 12 months, Ypsomed Holding paid a dividend of 1 CHF . This corresponds to a dividend yield of about 0.24 %. For the coming 12 months, Ypsomed Holding is expected to pay a dividend of 1.03 CHF.

What is the dividend yield of Ypsomed Holding?

The current dividend yield of Ypsomed Holding is 0.24 %.

When does Ypsomed Holding pay dividends?

Ypsomed Holding pays a quarterly dividend. This is distributed in the months of August, August, August, August.

How secure is the dividend of Ypsomed Holding?

Ypsomed Holding paid dividends every year for the past 0 years.

What is the dividend of Ypsomed Holding?

For the upcoming 12 months, dividends amounting to 1.03 CHF are expected. This corresponds to a dividend yield of 0.25 %.

In which sector is Ypsomed Holding located?

Ypsomed Holding is assigned to the 'Health' sector.

Wann musste ich die Aktien von Ypsomed Holding kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Ypsomed Holding from 7/3/2024 amounting to 1 CHF, you needed to have the stock in your portfolio before the ex-date on 7/1/2024.

When did Ypsomed Holding pay the last dividend?

The last dividend was paid out on 7/3/2024.

What was the dividend of Ypsomed Holding in the year 2023?

In the year 2023, Ypsomed Holding distributed 0.65 CHF as dividends.

In which currency does Ypsomed Holding pay out the dividend?

The dividends of Ypsomed Holding are distributed in CHF.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Ypsomed Holding

Our stock analysis for Ypsomed Holding Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ypsomed Holding Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.